Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Waddington, JL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 103 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Meagher, D; Quinn, J; Murphy, P; Kinsella, A; Mullaney, J; Waddington, JL
      Relationship of the factor structure of psychopathology in schizophrenia to the timing of initial intervention with antipsychotics

      SCHIZOPHRENIA RESEARCH
    2. Quinn, J; Meagher, D; Murphy, P; Kinsella, A; Mullaney, J; Waddington, JL
      Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction

      SCHIZOPHRENIA RESEARCH
    3. Clifford, JJ; Kinsella, A; Tighe, O; Rubinstein, M; Grandy, DK; Low, MJ; Croke, DT; Waddington, JL
      Comparative, topographically-based evaluation of behavioural phenotype andspecification of D-1-like: D-2 interactions in a line of incipient congenic mice with D-2 dopamine receptor "knockout"

      NEUROPSYCHOPHARMACOLOGY
    4. Waddington, JL; Clifford, JJ; McNamara, FN; Tomiyama, K; Koshikawa, N; Croke, DT
      The psychopharmacology-molecular biology interface: Exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout')

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    5. Hasegawa, M; Adachi, K; Nakamura, S; Sato, M; Waddington, JL; Koshikawa, N
      Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D-1-like receptors in jaw movements

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. Tomiyama, K; McNamara, FN; Clifford, JJ; Kinsella, A; Koshikawa, N; Waddington, JL
      Topographical assessment and pharmacological characterization of orofacialmovements in mice: dopamine D-1-like vs. D-2-like receptor regulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Clifford, JJ; Waddington, JL
      Topographically based search for an "ethogram" among a series of novel D-4dopamine receptor agonists and antagonists

      NEUROPSYCHOPHARMACOLOGY
    8. Ross, SA; Wong, JYF; Clifford, JJ; Kinsella, A; Massalas, JS; Horne, MK; Scheffer, IE; Kola, I; Waddington, JL; Berkovic, SF; Drago, J
      Phenotypic characterization of an alpha(4) neuronal nicotinic acetylcholine receptor subunit knock-out mouse

      JOURNAL OF NEUROSCIENCE
    9. Browne, S; Clarke, M; Gervin, M; Lane, A; Waddington, JL; Larkin, C; O'Callaghan, E
      Determinants of neurological dysfunction in first episode schizophrenia

      PSYCHOLOGICAL MEDICINE
    10. Clifford, JJ; Usiello, A; Vallone, D; Kinsella, A; Borrelli, E; Waddington, JL
      Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D-2 dopamine receptor

      NEUROPHARMACOLOGY
    11. Browne, S; Clarke, M; Gervin, M; Waddington, JL; Larkin, C; O'Callaghan, E
      Determinants of quality of life at first presentation with schizophrenia

      BRITISH JOURNAL OF PSYCHIATRY
    12. Waddington, JL
      Nature of obstetric complications in schizophrenia

      BRITISH JOURNAL OF PSYCHIATRY
    13. Quinn, J; Moran, M; Lane, A; Kinsella, A; Waddington, JL
      Long-term adaptive life functioning in relation to initiation of treatmentwith antipsychotics over the lifetime trajectory of schizophrenia

      BIOLOGICAL PSYCHIATRY
    14. Youssef, HA; Scully, PJ; Kinsella, A; Waddington, JL
      Geographical variation in rate of schizophrenia in rural Ireland by place at birth vs place at onset

      SCHIZOPHRENIA RESEARCH
    15. Clifford, JJ; Tighe, O; Croke, DT; Kinsella, A; Sibley, DR; Drago, J; Waddington, JL
      Conservation of behavioural topography to dopamine D-1-like receptor agonists in mutant mice lacking the D-1A receptor implicates a D-1-like receptornot coupled to adenylyl cyclase

      NEUROSCIENCE
    16. Waddington, JL; Lane, A; Scully, P; Meagher, D; Quinn, J; Larkin, C; O'Callaghan, E
      Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to 'neuroprogressive' process

      JOURNAL OF PSYCHIATRIC RESEARCH
    17. Adachi, K; Ikeda, H; Hasegawa, M; Nakamura, S; Waddington, JL; Koshikawa, N
      SK & F 83959 and non-cyclase-coupled dopamine D-1-like receptors in jaw movements via dopamine D-1-like/D-2-like receptor synergism

      EUROPEAN JOURNAL OF PHARMACOLOGY
    18. Waddington, JL; Youssef, HA; Kinsella, A
      Antipsychotic polypharmacy and early death - Reply

      BRITISH JOURNAL OF PSYCHIATRY
    19. Waddington, JL; Lane, A; Larkin, C; O'Callaghan, E
      The neurodevelopmental basis of schizophrenia: Clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease

      BIOLOGICAL PSYCHIATRY
    20. Waddington, JL; O'Callaghan, E; Youssef, HA; Buckley, P; Lane, A; Cotter, D; Larkin, C
      Schizophrenia: Evidence for a "cascade" process with neurodevelopmental origins

      PRENATAL EXPOSURES IN SCHIZOPHRENIA
    21. MEAGHER D; QUINN J; MURPHY P; KINSELLA A; MULLANEY J; WADDINGTON JL
      DURATION OF INITIALLY UNTREATED PSYCHOSIS PREDICTS SELECTIVELY THE PSYCHOMOTOR POVERTY FACTOR IN SCHIZOPHRENIA

      Schizophrenia research
    22. CLIFFORD JJ; WADDINGTON JL
      LACK OF PSYCHOPHARMACOLOGICAL SIGNATURE TO THE SELECTIVE D-4 ANTAGONIST L-745,870 AS EVALUATED ETHOLOGICALLY

      Schizophrenia research
    23. QUINN J; MEAGHER D; MURPHY P; KINSELLA A; MULLANEY J; WADDINGTON JL
      VULNERABILITY TO INVOLUNTARY MOVEMENTS OVER A LIFETIME OF SEVERE SCHIZOPHRENIA APPROACHES 100-PERCENT IN INTIMATE ASSOCIATION WITH FRONTAL-LOBE DYSFUNCTION

      Schizophrenia research
    24. BROWNE S; CLARKE M; GERVIN M; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      SOFT SIGNS IN FIRST EPISODE SCHIZOPHRENIA - EVIDENCE FOR TRAIT AND STATE PROCESSES INFLUENCING NEUROLOGICAL PERFORMANCE

      Schizophrenia research
    25. WADDINGTON JL; SCULLY PJ
      UNTREATED PSYCHOSIS AND LONG-TERM OUTCOME IN SCHIZOPHRENIA

      Schizophrenia bulletin
    26. WADDINGTON JL; LANE A; SCULLY PJ; LARKIN C; OCALLAGHAN E
      NEURODEVELOPMENTAL AND NEUROPROGRESSIVE PROCESSES IN SCHIZOPHRENIA - ANTITHETICAL OR COMPLEMENTARY, OVER A LIFETIME TRAJECTORY OF DISEASE

      The Psychiatric clinics of North America
    27. Clifford, JJ; Tighe, O; Croke, DT; Sibley, DR; Drago, J; Waddington, JL
      Topographical evaluation of the phenotype of spontaneous behaviour in micewith targeted gene deletion of the D-1A dopamine receptor: paradoxical elevation of grooming syntax

      NEUROPHARMACOLOGY
    28. CLIFFORD JJ; TIGHE O; CROKE DT; DRAGO J; SIBLEY DR; WADDINGTON JL
      TARGETED GENE DELETION OF THE D-1A DOPAMINE-RECEPTOR - BEHAVIORAL TOPOGRAPHY TO D-1-LIKE AND D-2-LIKE AGONISTS

      Naunyn-Schmiedeberg's archives of pharmacology
    29. WADDINGTON JL; BUCKLEY PF; SCULLY PJ; LANE A; OCALLAGHAN E; LARKIN C
      COURSE OF PSYCHOPATHOLOGY, COGNITION AND NEUROBIOLOGICAL ABNORMALITY IN SCHIZOPHRENIA - DEVELOPMENTAL ORIGINS AND AMELIORATION BY ANTIPSYCHOTICS

      Journal of Psychiatric Research
    30. WADDINGTON JL; YOUSSEF HA; KINSELLA A
      MORTALITY IN SCHIZOPHRENIA - ANTIPSYCHOTIC POLYPHARMACY AND ABSENCE OF ADJUNCTIVE ANTICHOLINERGICS OVER THE COURSE OF A 10-YEAR PROSPECTIVE-STUDY

      British Journal of Psychiatry
    31. CLIFFORD JJ; TIGHE O; CROKE DT; DRAGO J; SIBLEY DR; WADDINGTON JL
      BEHAVIORAL RESPONSIVITY TO THE SELECTIVE D-2-LIKE AGONIST RU-24213 INTRANSGENIC MICE WITH D-1A DOPAMINE-RECEPTOR KNOCKOUT

      British Journal of Pharmacology
    32. CLIFFORD JJ; TIGHE O; CROKE DT; DRAGO J; SIBLEY DR; WADDINGTON JL
      BEHAVIORAL RESPONSIVITY TO THE SELECTIVE D-1-LIKE AGONIST A-68930 IN TRANSGENIC MICE WITH D-1A DOPAMINE-RECEPTOR KNOCKOUT

      British Journal of Pharmacology
    33. CLIFFORD JJ; TIGHE O; CROKE DT; DRAGO J; SIBLEY DR; WADDINGTON JL
      BEHAVIORAL TOPOGRAPHY TO D-1-LIKE AND D-2-LIKE AGONISTS FOLLOWING D(1)A DOPAMINE-RECEPTOR KNOCKOUT

      Brain research
    34. GERVIN M; BROWNE S; LANE A; CLARKE M; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      SPONTANEOUS ABNORMAL INVOLUNTARY MOVEMENTS IN FIRST-EPISODE SCHIZOPHRENIA AND SCHIZOPHRENIFORM DISORDER - BASE-LINE RATE IN A GROUP OF PATIENTS FROM AN IRISH CATCHMENT-AREA

      The American journal of psychiatry
    35. CLIFFORD JJ; WADDINGTON JL
      HETEROGENEITY OF BEHAVIORAL PROFILE BETWEEN 3 NEW PUTATIVE SELECTIVE D-3-DOPAMINE-RECEPTOR ANTAGONISTS USING AN ETHOLOGICALLY BASED APPROACH

      Psychopharmacology
    36. WADDINGTON JL; OCALLAGHAN E
      WHAT MAKES AN ANTIPSYCHOTIC ATYPICAL - CONSERVING THE DEFINITION

      CNS DRUGS
    37. WADDINGTON JL; SCULLY PJ; OCALLAGHAN E
      THE NEW ANTIPSYCHOTICS, AND THEIR POTENTIAL FOR EARLY INTERVENTION INSCHIZOPHRENIA

      Schizophrenia research
    38. SCULLY PJ; COAKLEY G; KINSELLA A; WADDINGTON JL
      NEGATIVE SYMPTOM SEVERITY AND GENERAL COGNITIVE IMPAIRMENT INCREASE WITH DURATION OF INITIALLY UNTREATED PSYCHOSIS

      Schizophrenia research
    39. LANE A; LARIN C; WADDINGTON JL; OCALLAGHAN E
      UPWARD SHIFT IN THE DISTRIBUTION OF DYSMORPHIC FEATURES IN SCHIZOPHRENIA

      Schizophrenia research
    40. CLIFFORD J; WADDINGTON JL
      SYSTEMATIC COMPARISON OF THE BEHAVIORAL PROFILES OF 3 NEW D-3 DOPAMINE-RECEPTOR ANTAGONISTS

      Schizophrenia research
    41. BROWNE S; GERVIN M; LANE A; MORRIS M; LARKIN C; WADDINGTON JL; OCALLAGHAN E
      QUALITY-OF-LIFE IN FIRST EPISODE SCHIZOPHRENIA SCHIZOPHRENIFORM DISORDER/

      Schizophrenia research
    42. BROWNE S; GERVIN M; LANE A; MORRIS M; LARKIN C; WADDINGTON JL; OCALLAGHAN E
      NEUROLOGICAL SOFT SIGNS IN FIRST EPISODE SCHIZOPHRENIA SCHIZOPHRENIFORM PSYCHOSIS/

      Schizophrenia research
    43. WADDINGTON JL; YOUSSEF HA; KINSELLA A
      MORTALITY IN SCHIZOPHRENIA INCREASES WITH NEUROLEPTIC POLYPHARMACY AND ABSENCE OF ADJUNCTIVE ANTICHOLINERGICS - A 10-YEAR PROSPECTIVE-STUDY

      Schizophrenia research
    44. GERVIN M; BROWNE S; LANE A; CLARKE M; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      SPONTANEOUS DYSKINESIA IN FIRST EPISODE SCHIZOPHRENIA SCHIZOPHRENIFORM PSYCHOSIS/

      Schizophrenia research
    45. WADDINGTON JL; SCULLY PJ; YOUSSEF HA
      DEVELOPMENTAL TRAJECTORY AND DISEASE PROGRESSION IN SCHIZOPHRENIA - THE CONUNDRUM, AND INSIGHTS FROM A 12-YEAR PROSPECTIVE-STUDY IN THE MONAGHAN-101

      Schizophrenia research
    46. WADDINGTON JL; TORREY EF; KINSELLA A
      LOCAL GEOGRAPHICAL VARIATION IN THE PREVALENCE OF SCHIZOPHRENIA IN COROSCOMMON, IRELAND, IN JUXTAPOSITION WITH CASES OF BIPOLAR DISORDER

      Schizophrenia research
    47. DEVENEY AM; WADDINGTON JL
      PSYCHOPHARMACOLOGICAL DISTINCTION BETWEEN NOVEL FULL-EFFICACY D-1-LIKE DOPAMINE-RECEPTOR AGONISTS

      Pharmacology, biochemistry and behavior
    48. SCULLY PJ; COAKLEY G; KINSELLA A; WADDINGTON JL
      PSYCHOPATHOLOGY, EXECUTIVE (FRONTAL) AND GENERAL COGNITIVE IMPAIRMENTIN RELATION TO DURATION OF INITIALLY UNTREATED VERSUS SUBSEQUENTLY TREATED PSYCHOSIS IN CHRONIC-SCHIZOPHRENIA

      Psychological medicine
    49. LANE A; KINSELLA A; MURPHY P; BYRNE M; KEENAN J; COLGAN K; CASSIDY B; SHEPPARD N; HORGAN R; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      THE ANTHROPOMETRIC ASSESSMENT OF DYSMORPHIC FEATURES IN SCHIZOPHRENIAAS AN INDEX OF ITS DEVELOPMENTAL ORIGINS

      Psychological medicine
    50. SCULLY PJ; COAKLEY G; KINSELLA A; WADDINGTON JL
      EXECUTIVE (FRONTAL) DYSFUNCTION AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - APPARENT GENDER DIFFERENCES IN STATIC V PROGRESSIVE PROFILES

      British Journal of Psychiatry
    51. CLIFFORD J; WADDINGTON JL
      3 NEW D-3 DOPAMINE-RECEPTOR ANTAGONISTS - SYSTEMATIC COMPARISON OF BEHAVIORAL PROFILES

      British Journal of Pharmacology
    52. CLIFFORD J; TIGHE O; CROKE DT; DRAGO J; SIBLEY DR; WADDINGTON JL
      PHENOTYPE OF SPONTANEOUS BEHAVIOR IN TRANSGENIC MICE WITH D-1A DOPAMINE-RECEPTOR KNOCKOUT

      British Journal of Pharmacology
    53. YOUSSEF HA; SCULLY P; KINSELLA A; WADDINGTON JL
      GEOGRAPHIC-VARIATION IN RATE OF SCHIZOPHRENIA BY PLACE OF BIRTH VS PLACE AT ONSET OF ILLNESS IN RURAL IRELAND, AND ITS GENDER CHARACTERISTICS

      Schizophrenia research
    54. WADDINGTON JL; YOUSSEF HA; KINSELLA A
      ASSOCIATION BETWEEN EXTENT OF NEUROLEPTIC POLYPHARMACY AND REDUCED SURVIVAL IN A 10-YEAR PROSPECTIVE-STUDY OF MORTALITY IN SCHIZOPHRENIA

      Schizophrenia research
    55. LANE A; KINSELLA A; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      QUANTITATIVE EVIDENCE OF DEVELOPMENTAL INSTABILITY IN SCHIZOPHRENIA AS MEASURED BY FLUCTUATING ASYMMETRY

      Schizophrenia research
    56. SCULLY P; COAKLEY G; YOUSSEF HA; WADDINGTON JL
      EXECUTIVE DYSFUNCTION IN SCHIZOPHRENIA INTIMATELY RELATED TO NEGATIVESYMPTOMS

      Schizophrenia research
    57. WADDINGTON JL; DEVENEY AM
      DOPAMINE-RECEPTOR MULTIPLICITY - D-1-LIKE-D-2-LIKE INTERACTIONS AND D-1-LIKE RECEPTORS NOT LINKED TO ADENYLATE-CYCLASE

      Biochemical Society transactions
    58. LANE A; COLGAN K; MOYNIHAN F; BURKE T; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      SCHIZOPHRENIA AND NEUROLOGICAL SOFT SIGNS - GENDER DIFFERENCES IN CLINICAL CORRELATES AND ANTECEDENT FACTORS

      Psychiatry research
    59. WADDINGTON JL; YOUSSEF HA
      COGNITIVE DYSFUNCTION IN CHRONIC-SCHIZOPHRENIA FOLLOWED PROSPECTIVELYOVER 10 YEARS AND ITS LONGITUDINAL RELATIONSHIP TO THE EMERGENCE OF TARDIVE-DYSKINESIA

      Psychological medicine
    60. DEVENEY AM; WADDINGTON JL
      EVIDENCE FOR DOPAMINE D-1-LIKE RECEPTOR SUBTYPES IN THE BEHAVIORAL-EFFECTS OF 2 NEW SELECTIVE ANTAGONISTS, LY-270411 AND BW-737C

      European journal of pharmacology
    61. WADDINGTON JL
      ADVANCES IN THE NEUROBIOLOGY OF SCHIZOPHRENIA - DENBOER,JA, WESTENBERG,HGM, VANPRAAG,HM

      The American journal of psychiatry
    62. WADDINGTON JL; YOUSSEF HA
      FAMILIAL GENETIC AND REPRODUCTIVE EPIDEMIOLOGY OF SCHIZOPHRENIA IN RURAL IRELAND - AGE AT ONSET, FAMILIAL MORBID RISK AND PARENTAL FERTILITY

      Acta psychiatrica Scandinavica
    63. DEVENEY AM; WADDINGTON JL
      COMPARISON OF THE NEW ATYPICAL ANTIPSYCHOTICS OLANZAPINE AND ICI-204,636 WITH CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE SELECTIVE D-1 LIKE DOPAMINE-RECEPTOR AGONIST A-68930 AND SELECTIVE D-2-LIKE AGONIST RU-24213

      Psychopharmacology
    64. BUCKLEY P; OCALLAGHAN E; MULVANY F; LARKIN C; STACK JP; REDMOND O; ENNIS JT; THOMPSON P; WADDINGTON JL
      BASAL GANGLIA T-2 RELAXATION-TIMES IN SCHIZOPHRENIA - A QUANTITATIVE MAGNETIC-RESONANCE-IMAGING STUDY IN RELATION TO TARDIVE-DYSKINESIA

      PSYCHIATRY RESEARCH-NEUROIMAGING
    65. WADDINGTON JL; YOUSSEF HA; FARRELL MA; TOLAND J
      INITIAL SCHIZOPHRENIA-LIKE PSYCHOSIS IN PICKS-DISEASE - CASE-STUDY WITH NEUROIMAGING AND NEUROPATHOLOGY, AND IMPLICATIONS FOR FRONTOTEMPORAL DYSFUNCTION IN SCHIZOPHRENIA

      Schizophrenia research
    66. WADDINGTON JL; YOUSSEF HA
      PARENTAL FERTILITY IN SCHIZOPHRENIA - INTERACTION WITH PROBAND FAMILIAL-GENETIC LOADING AND AGE AT ONSET

      Schizophrenia research
    67. YOUSSEF HA; WADDINGTON JL
      COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA FOLLOWED PROSPECTIVELY OVER 10YEARS - STATIC ENCEPHALOPATHY VS DETERIORATION WITH EMERGENCE OF TARDIVE-DYSKINESIA

      Schizophrenia research
    68. DEVENEY AM; WADDINGTON JL
      PREFERENTIAL INTERACTION OF THE NEW PUTATIVE ATYPICAL ANTIPSYCHOTICS OLANZAPINE AND ICI-204-636 [SEROQUEL(R)] AND OF CLOZAPINE WITH D-1 VS D-2 RECEPTOR SYSTEMS

      Schizophrenia research
    69. YOUSSEF HA; WADDINGTON JL
      10-YEAR PROSPECTIVE-STUDY OF SEVERE NEGATIVE SYMPTOMS IN RELATION TO DURATION OF INITIALLY UNTREATED PSYCHOSIS IN SCHIZOPHRENIA

      Schizophrenia research
    70. WADDINGTON JL; OCALLAGHAN E; BUCKLEY P; MADIGAN C; REDMOND O; STACK JP; KINSELLA A
      DEVELOPMENTAL PRECURSORS OF TARDIVE-DYSKINESIA IN SCHIZOPHRENIA - MINOR PHYSICAL ANOMALIES, FRONTAL-LOBE DYSFUNCTION AND CEREBRAL STRUCTUREON MRI

      Schizophrenia research
    71. WADDINGTON JL; DALY SA; DOWNES RP; DEVENEY AM; MCCAULEY PG; OBOYLE KM
      BEHAVIORAL PHARMACOLOGY OF D-1-LIKE DOPAMINE-RECEPTORS - FURTHER SUBTYPING, NEW PHARMACOLOGICAL PROBES AND INTERACTIONS WITH D-2-LIKE RECEPTORS

      Progress in neuro-psychopharmacology & biological psychiatry
    72. WADDINGTON JL; YOUSSEF HA; KINSELLA A
      SEQUENTIAL CROSS-SECTIONAL AND 10-YEAR PROSPECTIVE-STUDY OF SEVERE NEGATIVE SYMPTOMS IN RELATION TO DURATION OF INITIALLY UNTREATED PSYCHOSIS IN CHRONIC-SCHIZOPHRENIA

      Psychological medicine
    73. MCCAULEY PG; OBOYLE KM; WADDINGTON JL
      DOPAMINE-INDUCED REDUCTION IN THE DENSITY OF GUANINE NUCLEOTIDE-SENSITIVE D-1 RECEPTORS IN HUMAN POSTMORTEM BRAIN IN THE ABSENCE OF APPARENT D-1-D-2 INTERACTIONS

      Neuropharmacology
    74. WADDINGTON JL; OCALLAGHAN E; BUCKLEY P; MADIGAN C; REDMOND O; STACK JP; KINSELLA A; LARKIN C; ENNIS JT
      TARDIVE-DYSKINESIA IN SCHIZOPHRENIA - RELATIONSHIP TO MINOR PHYSICAL ANOMALIES, FRONTAL-LOBE DYSFUNCTION AND CEREBRAL STRUCTURE ON MAGNETIC-RESONANCE-IMAGING

      British Journal of Psychiatry
    75. OCALLAGHAN E; COTTER D; COLGAN K; LARKIN C; WALSH D; WADDINGTON JL
      CONFINEMENT OF WINTER BIRTH EXCESS IN SCHIZOPHRENIA TO THE URBAN-BORNAND ITS GENDER SPECIFICITY

      British Journal of Psychiatry
    76. DEVENEY AM; WADDINGTON JL
      PHARMACOLOGICAL CHARACTERIZATION OF BEHAVIORAL-RESPONSES TO SK-AND-F-83959 IN RELATION TO D-1-LIKE DOPAMINE-RECEPTORS NOT LINKED TO ADENYLYL-CYCLASE

      British Journal of Pharmacology
    77. DEVENEY AM; WADDINGTON JL
      BEHAVIORAL-COMPARISON OF NOVEL, FULL EFFICACY DOPAMINE D-1-LIKE AGONISTS - DIHYDREXIDINE AND A-68930

      British Journal of Pharmacology
    78. DEVENEY AM; WADDINGTON JL
      EFFECTS OF OLANZAPINE AND ICI-204,636 ON BEHAVIORAL-RESPONSES TO THE D1-LIKE DOPAMINE-RECEPTOR AGONIST A-68930 - COMPARISONS WITH CLOZAPINE

      British Journal of Pharmacology
    79. OCALLAGHAN E; BUCKLEY P; MADIGAN C; REMOND O; STACK JP; KINSELLA A; LARKIN C; ENNIS JT; WADDINGTON JL
      THE RELATIONSHIP OF MINOR PHYSICAL ANOMALIES AND OTHER PUTATIVE INDEXES OF DEVELOPMENTAL DISTURBANCE IN SCHIZOPHRENIA TO ABNORMALITIES OF CEREBRAL STRUCTURE ON MAGNETIC-RESONANCE-IMAGING

      Biological psychiatry
    80. WADDINGTON JL; YOUSSEF HA; KINSELLA A
      THE PREVALENCE OF SCHIZOPHRENIA IN IRELAND - READDRESSING THE ENIGMA

      Archives of general psychiatry
    81. LANE A; BYRNE M; MULVANY F; KINSELLA A; WADDINGTON JL; WALSH D; LARKIN C; OCALLAGHAN E
      REPRODUCTIVE-BEHAVIOR IN SCHIZOPHRENIA RELATIVE TO OTHER MENTAL-DISORDERS - EVIDENCE FOR INCREASED FERTILITY IN MEN DESPITE DECREASED MARITAL RATE

      Acta psychiatrica Scandinavica
    82. LANE A; MURPHY P; CASSIDY B; COLGAN K; KINSELLA A; SHEPPARD N; HORGAN R; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      DISTURBED PRENATAL DEVELOPMENT IN SCHIZOPHRENIA AS EVIDENCED BY MINORPHYSICAL ANOMALIES

      Schizophrenia research
    83. WADDINGTON JL; YOUSSEF HA
      GENETIC EPIDEMIOLOGY OF SCHIZOPHRENIA IN RURAL IRELAND REVEALS A GENDER-SPECIFIC INTERACTION BETWEEN AGE AT ONSET AND FAMILY HISTORY

      Schizophrenia research
    84. YOUSSEF HA; KINSELLA A; WADDINGTON JL
      SPACE-TIME CLUSTERING IN THE BIRTHS OF SCHIZOPHRENIC-PATIENTS AND ITSRELATIONSHIP TO FAMILIAL MORBID RISK

      Schizophrenia research
    85. SLOAN D; COTTER D; GILLIGAN P; MCHENRY J; BYRNE M; LANE A; ENNIS JT; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      CORPUS-CALLOSUM MORPHOLOGICAL-CHARACTERISTICS OF SCHIZOPHRENIA AND ITS RELATIONSHIP TO INDEXES OF NEURODEVELOPMENTAL DISORDER

      Schizophrenia research
    86. BUCKLEY P; MOORE C; LONG H; LARKIN C; MULVANY F; REDMOND O; STACK JP; ENNIS JT; WADDINGTON JL
      SEXUAL DIMORPHISM, PUTATIVE NEURODEVELOPMENTAL AND COGNITIVE CORRELATES OF H-1 MAGNETIC-RESONANCE SPECTROSCOPY IN SCHIZOPHRENIA

      Schizophrenia research
    87. LANE A; COLGAN K; MOYNIHAN F; BURKE T; WADDINGTON JL; LARKIN C; OCALLAGHAN E
      NEUROLOGICAL SOFT SIGNS AND SCHIZOPHRENIA - GENDER DIFFERENCES IN CLINICAL CORRELATES AND PRESUMED ETIOLOGIC FACTORS

      Schizophrenia research
    88. WADDINGTON JL; LIEBERMAN JA
      NEW INSIGHTS INTO CLASSICAL ISSUES IN SCHIZOPHRENIA

      JOURNAL OF PSYCHOPHARMACOLOGY
    89. WADDINGTON JL
      GENETICS, CHANCE AND DYSMORPHOGENESIS IN SCHIZOPHRENIA

      British Journal of Psychiatry
    90. WADDINGTON JL; YOUSSEF HA
      EVIDENCE FOR A GENDER-SPECIFIC DECLINE IN THE RATE OF SCHIZOPHRENIA IN RURAL IRELAND OVER A 50-YEAR PERIOD

      British Journal of Psychiatry
    91. DALY SA; WADDINGTON JL
      THE EFFECTS OF CLOZAPINE ON BEHAVIORAL-RESPONSES TO THE SELECTIVE D-1-LIKE DOPAMINE-RECEPTOR AGONIST, A-68930, AND TO THE SELECTIVE D-2-LIKE AGONIST, RU-24213

      British Journal of Pharmacology
    92. DEVENEY AM; WADDINGTON JL
      PHARMACOLOGICAL CHARACTERIZATION OF BEHAVIORAL STIMULATION TO SK-AND-F-83959, A PARADOXICAL D-1-LIKE AGONIST THAT INHIBITS DOPAMINE-SENSITIVE ADENYLYL-CYCLASE

      British Journal of Pharmacology
    93. MCCAULEY PG; OBOYLE KM; WADDINGTON JL
      INVESTIGATION OF PUTATIVE D-1-D-2 DOPAMINE-RECEPTOR INTERACTIONS IN POSTMORTEM HUMAN BRAIN

      British Journal of Pharmacology
    94. BUCKLEY PF; WADDINGTON JL
      MAGNETIC-RESONANCE SPECTROSCOPY IN SCHIZOPHRENIA - A NASCENT TECHNOLOGY FOR A NEURODEVELOPMENTAL DISORDER

      Biological psychiatry
    95. BUCKLEY PF; MOORE C; LONG H; LARKIN C; THOMPSON P; MULVANY F; REDMOND O; STACK JP; ENNIS JT; WADDINGTON JL
      H-1-MAGNETIC RESONANCE SPECTROSCOPY OF THE LEFT TEMPORAL AND FRONTAL LOBES IN SCHIZOPHRENIA - CLINICAL, NEURODEVELOPMENTAL, AND COGNITIVE CORRELATES

      Biological psychiatry
    96. BUCKLEY P; MOORE C; LONG H; LARKIN C; MULVANY F; REDMOND O; STACK JP; ENNIS JT; WADDINGTON JL
      CORRELATES OF H-1-MAGNETIC RESONANCE SPECTROSCOPY IN SCHIZOPHRENIA

      Biological psychiatry
    97. WADDINGTON JL; OCALLAGHAN E; LARKIN C; KINSELLA A
      COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA - ORGANIC VULNERABILITY FACTOROR STATE MARKER FOR TARDIVE-DYSKINESIA

      Brain and cognition
    98. WADDINGTON JL
      SIGHT AND INSIGHT - VISUALIZATION OF AUDITORY HALLUCINATIONS IN SCHIZOPHRENIA

      Lancet
    99. DALY SA; WADDINGTON JL
      BEHAVIORAL-EFFECTS OF THE PUTATIVE D-3 DOPAMINE RECEPTOR AGONIST 7-OH-DPAT IN RELATION TO OTHER D-2-LIKE AGONISTS

      Neuropharmacology
    100. WADDINGTON JL; YOUSSEF HA; KINSELLA A
      CLINICAL CORRELATES OF DISTINCT TOPOGRAPHIES OF TARDIVE-DYSKINESIA INSCHIZOPHRENIA

      The American journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 13:57:13